Ignite Creation Date:
2024-05-06 @ 5:37 PM
Last Modification Date:
2024-10-26 @ 2:32 PM
Study NCT ID:
NCT05377827
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-10-12
First Post:
2022-05-11
Brief Title:
Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells WU-CART-007 in Patients With CD7 Hematologic Malignancies
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hepatosplenic T-cell Lymphoma |
| T-Cell Non-Hodgkin Lymphoma |
| Acute Myeloid Leukemia |
| Angioimmunoblastic T-cell Lymphoma |
| Enteropathy-Associated T-Cell Lymphoma |
| Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma |
| Peripheral T Cell Lymphoma |
| Anaplastic Large Cell Lymphoma |
| Adult T Cell Leukemia |
| Adult T Cell Lymphoma |
| T Cell Prolymphocytic Leukemia |
| Extranodal NKT-cell Lymphoma |
| Transformed Mycosis Fungoides |
| Sezary Syndrome |
| Primary Cutaneous Gamma-Delta T-Cell Lymphoma |
Keywords: